AU2002308337A1 - Compounds and methods for inhibiting axillary malodour - Google Patents

Compounds and methods for inhibiting axillary malodour

Info

Publication number
AU2002308337A1
AU2002308337A1 AU2002308337A AU2002308337A AU2002308337A1 AU 2002308337 A1 AU2002308337 A1 AU 2002308337A1 AU 2002308337 A AU2002308337 A AU 2002308337A AU 2002308337 A AU2002308337 A AU 2002308337A AU 2002308337 A1 AU2002308337 A1 AU 2002308337A1
Authority
AU
Australia
Prior art keywords
compounds
methods
axillary malodour
malodour
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002308337A
Other languages
English (en)
Inventor
Gonzalo Acuna
Marie-Claude Fournie-Zaluski
Hans Gfeller
Andreas Natsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Givaudan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan SA filed Critical Givaudan SA
Publication of AU2002308337A1 publication Critical patent/AU2002308337A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2002308337A 2001-05-14 2002-05-14 Compounds and methods for inhibiting axillary malodour Abandoned AU2002308337A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01111637A EP1258531A1 (en) 2001-05-14 2001-05-14 Compounds and methods for inhibiting axillary malodour
EP01111637.3 2001-05-14
PCT/CH2002/000262 WO2002092024A2 (en) 2001-05-14 2002-05-14 Compounds and methods for inhibiting axillary malodour

Publications (1)

Publication Number Publication Date
AU2002308337A1 true AU2002308337A1 (en) 2002-11-25

Family

ID=8177410

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002308337A Abandoned AU2002308337A1 (en) 2001-05-14 2002-05-14 Compounds and methods for inhibiting axillary malodour

Country Status (8)

Country Link
US (2) US7264956B2 (pt)
EP (3) EP1258531A1 (pt)
AT (1) ATE356876T1 (pt)
AU (1) AU2002308337A1 (pt)
BR (1) BR0209628A (pt)
DE (1) DE60218837T2 (pt)
MX (1) MXPA03010323A (pt)
WO (1) WO2002092024A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1258531A1 (en) 2001-05-14 2002-11-20 Givaudan SA Compounds and methods for inhibiting axillary malodour
WO2004031766A1 (ja) * 2002-10-04 2004-04-15 Kao Corporation 体臭判定用指標物質、その製造方法、体臭判定方法、デオドラント剤の有効性判定方法、体臭の簡易判定キット
GB0226550D0 (en) 2002-11-14 2002-12-18 Givaudan Sa Organic compounds
GB0227363D0 (en) * 2002-11-25 2002-12-31 Givaudan Sa Organic compounds
US20060159639A1 (en) 2003-03-03 2006-07-20 Miharu Ogura Pseudo body odor composition and perfume composition for inhibiting body odor
BRPI0607207B1 (pt) * 2005-01-31 2021-10-13 Firmenich S.A Método para triar compostos e composto para evitar mau odor no suor tendo a capacidade de reduzir o desenvolvimento de mau odor e para metabolizar um composto sob condições controladas
JP5431339B2 (ja) * 2007-10-10 2014-03-05 ジボダン エス エー 酵素学的方法および酵素
DE102008001811A1 (de) 2008-05-15 2009-11-19 Beiersdorf Ag Kosmetische Zubereitungen zur Verminderung von Schweißgeruch mit ABCC-Modulatoren
GB201018171D0 (en) 2010-10-28 2010-12-08 Givaudan Sa Organic compounds
BR112013015067A2 (pt) * 2010-12-17 2018-08-28 Basf Se padrões e inibidores de maus odores
WO2012084426A1 (en) * 2010-12-22 2012-06-28 Unilever Nv Enzymatic laundry detergent composition for the promotion of hygiene and the prevention of malodour
CN103328014A (zh) * 2011-01-27 2013-09-25 奇华顿股份有限公司 组合物
DE102011089012A1 (de) * 2011-12-19 2013-06-20 Henkel Ag & Co. Kgaa Textilschonende Antitranspirantien
CN107501024B (zh) * 2017-09-15 2021-06-29 安徽省科学技术研究院 一种1,2-二碘代烯烃类化合物的合成方法
US20220168208A1 (en) 2019-04-04 2022-06-02 Universiteit Gent Microbial enzymes to reduce malodour of skin and textiles
GB202104969D0 (en) 2021-04-08 2021-05-26 Givaudan Sa Fragrance composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934004A (en) * 1973-03-09 1976-01-20 Orren Leonard J Stain resistant anti-perspirant composition
US4745067A (en) * 1985-05-02 1988-05-17 Microbial Chemistry Research Foundation L-aminoacylases
US5643559A (en) * 1991-10-30 1997-07-01 Colgate-Palmolive Company Deodorant compositions comprising inhibitors of odor-producing axillary bacterial exoenzymes
EP0815833B1 (en) * 1996-06-24 2003-04-09 Givaudan SA Malodour preventing agents
DE19652284A1 (de) 1996-12-16 1998-06-18 Hoechst Schering Agrevo Gmbh Neue Gene codierend für Aminosäure-Deacetylasen mit Spezifität für N-Acetyl-L-Phosphinothricin, ihre Isolierung und Verwendung
US5861145A (en) * 1997-06-09 1999-01-19 The Procter & Gamble Company Method of reducing body odor using perfumed, odor absorbing, two phase compositions
GB9814653D0 (en) 1998-07-07 1998-09-02 Quest Int Method of reducing or preventing malodour
GB9814733D0 (en) 1998-07-07 1998-09-02 Unilever Plc Method of reducing or preventing malodour
DE19855956C2 (de) 1998-12-04 2000-11-02 Cognis Deutschland Gmbh Sterolphosphate
DE19858811A1 (de) 1998-12-21 2000-06-29 Cognis Deutschland Gmbh Desodorierende kosmetische Mittel
JP2000288076A (ja) * 1999-04-07 2000-10-17 Lion Corp 芳香消臭剤組成物
EP1258531A1 (en) 2001-05-14 2002-11-20 Givaudan SA Compounds and methods for inhibiting axillary malodour

Also Published As

Publication number Publication date
WO2002092024A2 (en) 2002-11-21
BR0209628A (pt) 2004-06-22
US7264956B2 (en) 2007-09-04
EP1258531A1 (en) 2002-11-20
EP1811034A3 (en) 2011-03-16
EP1811034B1 (en) 2014-04-09
EP1387891A2 (en) 2004-02-11
US20040241795A1 (en) 2004-12-02
DE60218837T2 (de) 2007-11-15
DE60218837D1 (de) 2007-04-26
ATE356876T1 (de) 2007-04-15
MXPA03010323A (es) 2004-02-17
EP1811034A2 (en) 2007-07-25
US20100278768A1 (en) 2010-11-04
EP1387891B1 (en) 2007-03-14
WO2002092024A3 (en) 2003-10-16

Similar Documents

Publication Publication Date Title
AU2002308337A1 (en) Compounds and methods for inhibiting axillary malodour
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
YU3902A (sh) Imidazoimidazoli i triazoli kao anti-inflamatorna sredstva
IL160713A0 (en) Compositions containing oxyntomodulin for prevention or treatment of excess weight
WO2004004657A3 (en) Hiv integrase inhibitors
EP1444055A4 (en) BAND-CONSTRUCTED COMPOSITIONS FOR DEPOSITING ELECTRONIC STRUCTURES
EP1810970B8 (en) Therapeutic piperazine compounds
AU2003270325A8 (en) Compositions and kits for the removal of irritating compounds from bodily surfaces
AU2003228674A1 (en) Muscarinic antagonists
AU2002343661A1 (en) Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the teatment of cancer
WO2004087073A3 (en) Treatment of demyelinating conditions
PL369600A1 (en) Methods and compositions of novel triazine compounds
AU2002322481A1 (en) Use of r-nsaid compounds for anti-hiv treatment
HUP0402341A3 (en) Compositions containing thiazol-2-ylamines for the treatment of cancer
AU2002364711A1 (en) Substituted 5-hydroxy-indole compounds for the treatment of glaucoma
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU1040000A (en) Compositions comprising a mixture of bioflavonols
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i
MXPA03006468A (es) Composiciones para la prevencion o tratamiento de hepatopatia.
AU2002315612A1 (en) Fragrance and flavour compositions
AU2002226682A1 (en) Compositions for prevention or treatment of hepatopathy
HK1082727A1 (en) 2" oxo-voruscharin and derivatives thereof
AU2002337442A1 (en) Novel compositions and methods for diagnosis and treatment of lymphoma and leukemia
AU2002337868A1 (en) Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase